Retinal Vasculitis Secondary to Durvalumab

Antonio R. Andrade, Aina Moll‐Udina, Ruth Martín, Esther Cilveti, Olaia Subirà, Laura Disfetano, José García‐Arumí

Case Reports in Ophthalmology · 2020 · 18 citations · 7 references

DOIFull text

Open access

Concepts

Abstract

Ocular manifestations are very rarely reported as side effects to checkpoint inhibitors. We present a case of a 64-year-old Caucasian man in treatment with durvalumab for non-small-cell lung carcinoma who presented a retinal vasculitis with macular edema. After three boluses of methylprednisolone, the retinal vasculitis resolved and macular edema improved during follow-up. There was no need for durvalumab to be withdrawn.

References

7